SC
Seldon Capital Portfolio holdings
AUM
$230M
This Quarter Return
+5.86%
1 Year Return
+91.96%
3 Year Return
+343%
5 Year Return
–
10 Year Return
–
AUM
$155M
AUM Growth
–
Cap. Flow
+$155M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
53.45%
Holding
290
New
290
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Vanguard Total Stock Market ETF
VTI
|
$16.6M |
| 2 |
iShares TIPS Bond ETF
TIP
|
$12.4M |
| 3 |
Vanguard Consumer Staples ETF
VDC
|
$9.91M |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
$8.48M |
| 5 |
Vanguard Total World Stock ETF
VT
|
$8.12M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Technology | 15.85% |
| 2 | Consumer Discretionary | 6.25% |
| 3 | Financials | 4.87% |
| 4 | Communication Services | 3.84% |
| 5 | Materials | 2.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Eli Lilly
LLY
$661B
| $112K | 0.07% |
+404
| New | +$112K |
|
102
Invesco DB Base Metals Fund
DBB
$121M
| $111K | 0.07% |
+5,000
| New | +$111K |
|
103
Lam Research
LRCX
$124B
| $111K | 0.07% |
+154
| New | +$111K |
|
104
RELX
RELX
$83.7B
| $107K | 0.07% |
+3,285
| New | +$107K |
|
105
VanEck Intermediate Muni ETF
ITM
$1.93B
| $103K | 0.07% |
+2,000
| New | +$103K |
|
106
McDonald's
MCD
$226B
| $102K | 0.07% |
+379
| New | +$102K |
|
107
Novartis
NVS
$248B
| $102K | 0.07% |
+1,167
| New | +$102K |
|
108
Illinois Tool Works
ITW
$76.2B
| $100K | 0.06% |
+404
| New | +$100K |
|
109
Brookfield
BN
$97.7B
| $99K | 0.06% |
+1,633
| New | +$99K |
|
110
Diageo
DEO
$61.1B
| $94K | 0.06% |
+427
| New | +$94K |
|
111
CRH
CRH
$75.1B
| $93K | 0.06% |
+1,767
| New | +$93K |
|
112
Cigna
CI
$80.2B
| $92K | 0.06% |
+401
| New | +$92K |
|
113
Medtronic
MDT
$118B
| $91K | 0.06% |
+876
| New | +$91K |
|
114
Dr. Reddy's Laboratories
RDY
$11.8B
| $91K | 0.06% |
+1,390
| New | +$91K |
|
115
MSCI
MSCI
$42.7B
| $88K | 0.06% |
+143
| New | +$88K |
|
116
Invesco FTSE RAFI Emerging Markets ETF
PXH
$1.57B
| $88K | 0.06% |
+4,000
| New | +$88K |
|
117
Sanofi
SNY
$122B
| $85K | 0.05% |
+1,703
| New | +$85K |
|
118
AngloGold Ashanti
AU
$29.9B
| $84K | 0.05% |
+3,993
| New | +$84K |
|
119
Mid-America Apartment Communities
MAA
$16.8B
| $84K | 0.05% |
+366
| New | +$84K |
|
120
Roper Technologies
ROP
$56.4B
| $84K | 0.05% |
+170
| New | +$84K |
|
121
Nice
NICE
$8.48B
| $83K | 0.05% |
+273
| New | +$83K |
|
122
Qiagen
QGEN
$10.1B
| $83K | 0.05% |
+1,488
| New | +$83K |
|
123
AstraZeneca
AZN
$255B
| $82K | 0.05% |
+1,414
| New | +$82K |
|
124
Boston Scientific
BSX
$159B
| $82K | 0.05% |
+1,938
| New | +$82K |
|
125
National Grid
NGG
$68B
| $82K | 0.05% |
+1,136
| New | +$82K |
|